Amyris (AMRS) Misses Q2 EPS by 28c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Amyris Reports Second Quarter 2015 Financial Results
August 6, 2015 4:27 PM EDTFirst half cash revenue inflows of $35.5 million up 36% from same period of 2014. Second-quarter GAAP revenues of $7.8 million and first half GAAP revenues of $15.7 million, an increase of 2% over the first half of 2014 Launched bio-opioids initiative expected to enable low cost supply of active pharmaceutical ingredients to global market for chronic pain management products Executed entry into large and fast-growing food ingredients sector via multi-year, multi-million-dollar collaboration agreement with global food ingredients supplier Converted and restructured $180 million of debt and raised $25 million in a private placement in July 2015, resulting in almost 60%... More
Amyris Reports Second Quarter 2015 Financial Results
August 6, 2015 4:27 PM EDTFirst half cash revenue inflows of $35.5 million up 36% from same period of 2014. Second-quarter GAAP revenues of $7.8 million and first half GAAP revenues of $15.7 million, an increase of 2% over the first half of 2014 Launched bio-opioids initiative expected to enable low cost supply of active pharmaceutical ingredients to global market for chronic pain management products Executed entry into large and fast-growing food ingredients sector via multi-year, multi-million-dollar collaboration agreement with global food ingredients supplier Converted and restructured $180 million of debt and raised $25 million in a private placement in July 2015, resulting in almost 60%... More
